Leonard, C. E., Brensinger, C. M., Dawwas, G. K., Deo, R., Bilker, W. B., Soprano, S. E., . . . Hennessy, S. (2020). The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: Real-world evidence on thiazolidinedione safety. Cardiovasc Diabetol.
Citação norma ChicagoLeonard, Charles E., et al. "The Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia With Rosiglitazone Versus Pioglitazone: Real-world Evidence On Thiazolidinedione Safety." Cardiovasc Diabetol 2020.
MLA引文Leonard, Charles E., et al. "The Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia With Rosiglitazone Versus Pioglitazone: Real-world Evidence On Thiazolidinedione Safety." Cardiovasc Diabetol 2020.
警告：這些引文格式不一定是100％准確.